The down-regulation of E-cadherin (E-cad) is associated with tumor progression, the loss of differentiation, invasion, and metastasis, so it is considered a relevant biomarker of colon cancer prognosis [157]. This evidence concerns the gene CDH1 and malignant colon neoplasm.